(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 5.8% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.31%.
Icon's revenue in 2024 is $8,331,892,000.On average, 5 Wall Street analysts forecast ICLR's revenue for 2024 to be $704,940,530,729, with the lowest ICLR revenue forecast at $704,172,986,480, and the highest ICLR revenue forecast at $706,533,259,580. On average, 5 Wall Street analysts forecast ICLR's revenue for 2025 to be $764,485,169,229, with the lowest ICLR revenue forecast at $747,152,400,199, and the highest ICLR revenue forecast at $778,131,522,944.
In 2026, ICLR is forecast to generate $815,421,436,243 in revenue, with the lowest revenue forecast at $791,981,522,678 and the highest revenue forecast at $828,909,693,068.